IKK-3 Inhibitor,
862812-98-4,
CAY10576,
GSK319347A,
5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)-3-[(2-methanesulfonylphenyl)methoxy]thiophene-2-carbonitrile,
5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-[[2-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarbonitrile,
MLS006010828,
CHEMBL373751,
SCHEMBL3413628,
BDBM27452,
CHEBI:91459,
CTK8E9362,
DTXSID30469666,
LDTAHRLHGHFHKP-UHFFFAOYSA-N,
HMS3229F19,
HMS3303L12,
HMS3305M09,
BCP24906,
GSK 319347A,
1798AH,
ZINC19795634,
AKOS002364333,
CS-0047,
NCGC00242056-01,
NCGC00242056-02,
benzimidazole-thiophene carbonitrile, 12e,
HY-14682,
SMR004701755,
RT-011937,
EC-000.2375,
A11463,
W-5451,
AB01092120-01,
BRD-K51781482-001-02-1,
2-Thiophenecarbonitrile, 5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[2-(methylsulfonyl)phenyl]methoxy]-,
5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(methylsulfonyl)benzyl]oxy}thiophene-2-carbonitrile,
5-[5,6-Bis(methyloxy)-1H-benzimidazol-1-yl]-3-({[2-(methylsulfonyl)phenyl]methyl}oxy)-2-thiophenecarbonitrile,
C22H19N3O5S2,
CID11626927,
5-(5,6-dimethoxybenzoimidazol-1-yl)-3-[(2-methylsulfonylphenyl)methoxy]thiophene-2-carbonitrile,